Target
GTPase HRas
Ligand
BDBM50089960
Substrate
n/a
Meas. Tech.
ChEMBL_82664 (CHEMBL694129)
IC50
15±n/a nM
Citation
 Baraldi, PGRomagnoli, RBeria, ICozzi, PGeroni, CMongelli, NBianchi, NMischiati, CGambari, R Synthesis and antitumor activity of new benzoheterocyclic derivatives of distamycin A. J Med Chem 43:2675-84 (2000) [PubMed]  Article 
Target
Name:
GTPase HRas
Synonyms:
GTPase HRas, N-terminally processed | H-Ras | H-Ras-1 | HRAS | HRAS1 | Ha-Ras | His6-Ha-Ras-CVLS | RASH_HUMAN | Transforming protein p21 | Transforming protein p21/H-Ras-1 | Wild-type Ha-Ras | c-H-ras | p21ras
Type:
Other Protein Type
Mol. Mass.:
21293.37
Organism:
Homo sapiens (Human)
Description:
P01112
Residue:
189
Sequence:
MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQHKLRKLNPPDESGPGCMSCKCVLS
  
Inhibitor
Name:
BDBM50089960
Synonyms:
5-{4-[Bis-(2-chloro-ethyl)-amino]-benzoylamino}-1H-benzoimidazole-2-carboxylic acid (5-{5-[5-(2-carbamimidoyl-ethylcarbamoyl)-1-methyl-1H-pyrrol-3-ylcarbamoyl]-1-methyl-1H-pyrrol-3-ylcarbamoyl}-1-methyl-1H-pyrrol-3-yl)-amide; hydrochloride | CHEMBL552690
Type:
Small organic molecule
Emp. Form.:
C40H43Cl2N13O5
Mol. Mass.:
856.76
SMILES:
Cn1cc(NC(=O)c2cc(NC(=O)c3cc(NC(=O)c4nc5ccc(NC(=O)c6ccc(cc6)N(CCCl)CCCl)cc5[nH]4)cn3C)cn2C)cc1C(=O)NCCC(N)=N
Structure:
Search PDB for entries with ligand similarity: